Company / SG&A Expense
Inspire Medical Systems, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$624.6M
FY2025
5-year range
$127.9M / $624.6M
FY2021-FY2025
Trend
+17.9%
vs FY2024
Sector context
#60 of 158
Health Care
What the data says
At $625M, Inspire Medical Systems, Inc.'s sg&a expense ranks #99 of 158 in the Health Care sector. SG&A Expense has increased for 3 consecutive years, from $128M in FY2022 to $625M in FY2025.
Based on SEC 10-K filings.
$625M in FY2025 with a 5-year CAGR of +37.3%.
Increased from $452M to $625M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +69.7%
- 5-Year CAGR
- +37.3%
- 10-Year CAGR
- -
Sector benchmark
#99 of 158 in Health CareTop 62% of 158This company $624.6M Sector average $175.9B
▼
-99.6% below sector average
Key checks
Key Insights
- Inspire Medical Systems, Inc.'s sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +37.3%, indicating consistent growth.
- In FY2025, sg&a expense increased 17.9% year-over-year.
- Ranks #60 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $624.6M | +17.9% |
| FY2024 | $529.6M | +17.2% |
| FY2023 | $452.0M | +253.4% |
| FY2022 | $127.9M | -36.9% |
| FY2021 | $202.6M | +58.4% |
| FY2020 | $127.9M | +41.4% |
| FY2019 | $90.5M | +69.0% |
| FY2018 | $53.5M | +65.4% |
| FY2017 | $32.4M | +42.6% |
| FY2016 | $22.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026